BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zheng L, Shen CL, Li JM, Ma YL, Yan N, Tian XQ, Zhao YZ. Assessment of the Preventive Effect Against Diabetic Cardiomyopathy of FGF1-Loaded Nanoliposomes Combined With Microbubble Cavitation by Ultrasound. Front Pharmacol 2019;10:1535. [PMID: 31998132 DOI: 10.3389/fphar.2019.01535] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Xiao M, Tang Y, Wang J (a), Lu G, Niu J, Wang J (b), Li J, Liu Q, Wang Z, Huang Z, Guo Y, Gao T, Zhang X, Yue S, Gu J. A new FGF1 variant protects against adriamycin-induced cardiotoxicity via modulating p53 activity. Redox Biol 2022;49:102219. [PMID: 34990928 DOI: 10.1016/j.redox.2021.102219] [Reference Citation Analysis]
2 Qi Y, Li L, Feng G, Shao C, Cai Y, Wang Z. Research Progress of Imaging Methods for Detection of Microvascular Angina Pectoris in Diabetic Patients. Front Cardiovasc Med 2021;8:713971. [PMID: 34621798 DOI: 10.3389/fcvm.2021.713971] [Reference Citation Analysis]
3 Alphandéry E. Nanomaterials as Ultrasound Theragnostic Tools for Heart Disease Treatment/Diagnosis. Int J Mol Sci 2022;23:1683. [PMID: 35163604 DOI: 10.3390/ijms23031683] [Reference Citation Analysis]
4 Zhang X, Tian X, Li P, Zhu H, Zhou N, Fang Z, Yang Y, Jing Y, Yuan J. Ultrasound-targeted microbubble destruction promotes myocardial angiogenesis and functional improvements in rat model of diabetic cardiomyopathy. BMC Cardiovasc Disord 2021;21:21. [PMID: 33413110 DOI: 10.1186/s12872-020-01815-4] [Reference Citation Analysis]
5 Zhou NQ, Fang ZX, Huang N, Zuo Y, Qiu Y, Guo LJ, Song P, Xu J, Wan GR, Tian XQ, Yin YL, Li P. aFGF Targeted Mediated by Novel Nanoparticles-Microbubble Complex Combined With Ultrasound-Targeted Microbubble Destruction attenuates Doxorubicin-Induced Heart Failure via Anti-Apoptosis and Promoting Cardiac Angiogenesis. Front Pharmacol 2021;12:607785. [PMID: 33986662 DOI: 10.3389/fphar.2021.607785] [Reference Citation Analysis]
6 Xiao M, Tang Y, Wang A J, Wang B J, Lu G, Guo Y, Zhang J, Gu J. Regulatory role of endogenous and exogenous fibroblast growth factor 1 in the cardiovascular system and related diseases. Pharmacol Res 2021;169:105596. [PMID: 33831565 DOI: 10.1016/j.phrs.2021.105596] [Reference Citation Analysis]